Related references
Note: Only part of the references are listed.Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression
Sean I. Tracy et al.
HAEMATOLOGICA (2018)
Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression
Sean I. Tracy et al.
HAEMATOLOGICA (2018)
The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients
Akinao Okamoto et al.
HEMATOLOGICAL ONCOLOGY (2017)
Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma
J. -H. Liang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Epstein - Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update
Jung Yong Hong et al.
CURRENT OPINION IN ONCOLOGY (2015)
CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma
Wen-Yu Chuang et al.
VIRCHOWS ARCHIV (2015)
Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age
Ting-Xun Lu et al.
SCIENTIFIC REPORTS (2015)
EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
J. Y. Hong et al.
ANNALS OF ONCOLOGY (2015)
Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers
Chrysoula Daskalogianni et al.
JOURNAL OF PATHOLOGY (2015)
TNF-α Expression in Tumor Cells as a Novel Prognostic Marker for Diffuse Large B-cell Lymphoma, Not Otherwise Specified
Shoko Nakayama et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era
Ai Sato et al.
CANCER SCIENCE (2014)
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Enrique A. Mesri et al.
CELL HOST & MICROBE (2014)
Prevalence and Clinical Implications of Epstein-Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries
Chi Young Ok et al.
CLINICAL CANCER RESEARCH (2014)
Clinical Characteristics and Treatment Outcome in a Taiwanese Population of Patients with Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma
Chang-Hsien Lu et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)
Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time
Sheng-Tsung Chang et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
EBV-positive diffuse large B-cell lymphoma of the elderly
Chi Young Ok et al.
BLOOD (2013)
Epstein-Barr Virus in Diffuse Large B-Cell Lymphoma in Immunocompetent Patients in Japan is as Low as in Western Countries
Naoki Wada et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story
A. Bari et al.
ANNALS OF ONCOLOGY (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Multicentric primary intestinal EBV-positive diffuse large B cell lymphoma of the elderly presenting with perforation
Shih-Sung Chuang et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era
Marita Ziepert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma
Domingo Morales et al.
LEUKEMIA & LYMPHOMA (2010)
Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints
B. Gruhne et al.
ONCOGENE (2009)
The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma
Sarah Park et al.
BLOOD (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
Laurie H. Sehn et al.
BLOOD (2007)
Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab
M. S. Czuczman et al.
LEUKEMIA & LYMPHOMA (2006)
Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing
RJ Jones et al.
VIROLOGY (2003)
Induction of growth rate and transcriptional modulation of growth promoters and growth inhibitors in epithelial cells by EBV-LMP1
M Kleines et al.
VIRUS RESEARCH (2000)
Share Paper
